Olanzapine Tablet, Film Coated
Product Images NDC 70518-2698

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 70518-2698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Olanzapine 5 mg tablets, quantity 30, repackaged by RemedyRepack Inc., Indiana, PA. Manufactured by Macleods Pharma USA, Plainsboro, NJ. Includes NDC 70518-2698-00 and source NDC 33342-0068-44. Storage instructions: store at 20-25°C with excursions permitted to 15-30°C.*

FDA Label Image

138 (Olanzapine Tab Str)

Chemical structure diagram of an unspecified compound featuring a fused bicyclic ring system with nitrogen, sulfur, and methyl-substituted heterocyclic components, including a piperazine ring and a five-membered sulfur-containing ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.